Haleon plc Form 6-K Summary
Business Context and Reporting Period
Haleon plc filed this Form 6-K for September 2022 under SEC Commission File No. 001-41411. The filing contains a September 13, 2022 press release announcing a change to the timing of the company’s first-half 2022 results.
Haleon is a global consumer-health company operating in approximately 170 markets with more than 22,000 employees. Its principal categories include oral health, pain relief, respiratory health, digestive health, vitamins, minerals and supplements, and other consumer-health products.
Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other financial performance figures. It is an administrative announcement concerning the timing of the half-year results release.
Material Changes Versus the Prior Comparable Period
Haleon changed the scheduled release date for its HY 2022 results from Monday, September 19, 2022, to Tuesday, September 20, 2022. The change reflected the UK bank holiday for the State Funeral of Queen Elizabeth II.
Guidance, Outlook, Risks, and Unusual Items
- The HY 2022 results were scheduled for release at 7:00 a.m. British Summer Time, with a recorded presentation to follow.
- An analyst and investor question-and-answer call was scheduled for 11:30 a.m.; dial-in details were to be published with the results release.
- The filing provides no earnings guidance, financial outlook, risk update, contingency disclosure, or unusual financial item.
Important Facts to Verify
- Confirm the company’s reported HY 2022 revenue, profit, cash flow, margins, debt, and liquidity in the subsequent results filing.
- Review management’s HY 2022 outlook, guidance, and commentary on operating and market risks.
- Verify the September 20, 2022 results publication and the related investor presentation and Q&A materials.